Glioblastoma Clinical Trials in High Point, NC

Glioblastoma Clinical Trials in High Point, NC

View the best 10 glioblastoma medical studies in High Point, North Carolina. Access promising new therapies by applying to a High Point-based Glioblastoma clinical trial.

Trials in High Point, North Carolina

Here are the top 10 medical studies for glioblastoma in High Point, North Carolina

Image of UCLA / Jonsson Comprehensive Cancer Center in Los Angeles, United States.

Lapatinib Ditosylate

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 1
This trial is testing how well lapatinib ditosylate works in treating patients with high-grade glioma that has come back. Lapatinib ditosylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Image of Grandview Cancer Center in Birmingham, United States.

OptuneĀ®

Device

Recruiting1 award12 criteria
This trial is testing a new treatment for brain cancer that combines Optune with radiation and chemotherapy. The goal is to see if this new combination is more effective and has fewer side effects than current treatments.
Image of City of Hope Medical Center in Duarte, United States.

NSC-CRAd-S-pk7

Virus Therapy

Recruiting1 awardPhase 1
This trial is testing a new cancer treatment consisting of neural stem cells that carry a virus. The hope is that this will kill more tumor cells than the current standard of care.
Image of University of Alabama at Birmingham in Birmingham, United States.

VAL-083 +7 More

Alkylating agents

Recruiting1 awardPhase 2 & 3
This trial is testing various treatments for patients with newly diagnosed or returning brain cancer. It adjusts treatments based on how well patients are doing to find the most effective options. The goal is to improve survival rates by matching the best treatments to specific patient types.
Image of Saint Joseph's Hospital and Medical Center in Phoenix, United States.

Bevacizumab

Monoclonal Antibodies

Recruiting1 award
This trial uses DSC-MRI to measure rCBV to determine response to bevacizumab in patients with recurrent glioblastoma. DSC-MRI may help to evaluate changes in cancer blood vessels.
Image of Northwestern University in Chicago, United States.

Carboplatin

Chemotherapy

Recruiting2 awardsPhase 3
This trial tests a new method to treat recurrent brain cancer using an ultrasound device called SonoCloud-9. The device helps open the brain's protective barrier so that more of the chemotherapy drug carboplatin can reach the tumor. The goal is to see if this combination makes the treatment more effective. Carboplatin has been used in various studies for treating high-grade gliomas and glioblastomas, often showing modest efficacy due to low tissue concentration when delivered intravenously.
Image of Lineberger Comprehensive Cancer Center in Chapel Hill, United States.

CAR.B7-H3T cells

CAR T-cell Therapy

Recruiting1 awardPhase 1
This trial is testing if it's safe to use CAR.B7-H3T cells, a treatment for glioblastoma that hasn't been tested on humans before.
Image of Duke University in Durham, United States.

Atezolizumab

Checkpoint Inhibitor

Recruiting1 awardPhase 2
"This trial aims to see if giving atezolizumab before surgery can help patients with recurrent glioblastoma and low mutational burden."
Image of Children's Hospital Colorado in Aurora, United States.

Lutathera

Radioisotope Therapy

Recruiting1 awardPhase 1 & 2
This trial tests Lutathera, a radioactive drug given through an IV, in patients with certain brain tumors that haven't responded to other treatments. The drug attaches to cancer cells and uses radiation to kill them.
Image of University of Arizona in Tucson, United States.

NanO2TM

Oxygen Enhancer

Recruiting0 awardsPhase 2
This trial is testing a new treatment that delivers more oxygen to tumors. It aims to help patients with a specific type of brain cancer by making radiation therapy more effective. By increasing oxygen levels in the tumor, the treatment helps radiation work better at killing cancer cells.

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' ā€” so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back ā€” in general, verified trials respond to patients within a few days.